Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

There were empty seats in San Francisco last week at an annual international science conference that has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Groundbreaking South African HIV cure trial shows 20% of participants maintaining viral suppression without medication for 18 months, marking a significant milestone in HIV research.

Rising infections highlight gaps in prevention efforts as experts urge expanded outreach and awareness campaigns ...

THE Tanzania Commission for AIDS (TACAIDS) has urged mining companies in Kahama District, Shinyanga Region, to introduce male ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...